Annita Tanini
CIK: 0002146784
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KROS
Keros Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Tanini Annita
Tanini Annita (SEC CIK 0002146784) files insider reports with the SEC as Corp. Controller & VP, Finance of Keros Therapeutics, Inc. (KROS).
Signal8 holds 2 ownership filings by Tanini Annita (1 Form 3, 1 Form 4), filed between Aug 13, 2026 and Aug 20, 2026. Those filings report 1 transaction, the latest on Aug 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Tanini Annita's filings is in LEXINGTON, MA.
Recent filings by Tanini Annita
- Aug 18, 2026: Open-market sale of KROS shares (Form 4, code S).
Other insiders filing for Keros Therapeutics, Inc. (KROS)
- Lerner Lorena Raquel, Chief Scientific Officer
- Cho Esther, Chief Legal Officer
- Newton Charles W., Director
- BIENAIME JEAN JACQUES, Director
- Prener Anne, Director
- Farzan Nima, Director